China and India Manufacturing: Risks and FDA Monitoring in Pharmaceuticals
China and India dominate global pharmaceutical manufacturing, but FDA monitoring reveals stark differences in compliance. India leads in regulatory reliability, while China offers scale - but with higher risk. Here’s what it means for drug safety and supply chains.
View more